RESUMO
INTRODUCTION: The objective of this study was to describe the incidence, microbiology, and risk factors related to infectious complications after transrectal prostate biopsies. METHODS: This was a single-center, retrospective cohort study of patients undergoing prostate biopsies. Throughout the study period, the institutional recommendation for antibiotic prophylaxis was cephalexin and ciprofloxacin. Due to the desire to limit fluoroquinolone use, the ciprofloxacin duration of therapy was reduced from 48 to 24 hours in the middle of the study period. The primary outcome was the incidence of infection-related complications, defined as a urinary tract infection (UTI) or bacteremia within 30 days post-procedure. RESULTS: A total of 1471 transrectal prostate biopsies were included. All patients received antibiotic prophylaxis, with 86.1% (1268/1472) of patients receiving both ciprofloxacin and cephalexin. The incidence of infection-related complications was 1.6% (24/1471). Four patients experienced bacteremia, all of which were due to E. coli, and all of these patients had received antibiotic prophylaxis with an active antibiotic. The use of ciprofloxacin was associated with a lower risk of infection-related complications (odds ratio [OR ] 0.20, 95% confidence interval [CI] 0.07, 0.55). Bacteriuria within one year prior to the procedure was associated with increased risk of infection-related complications (OR 4.77, 95% CI 1.34, 16.93). Four (0.3%) patients experienced an antibiotic-related adverse event. CONCLUSIONS: We observed a low rate of infection-related complications and antibiotic-related adverse events in the setting of antibiotic prophylaxis with ciprofloxacin and cephalexin for 24 hours, without pre-procedure rectal culture screening. Investigation into procedural or host factors may uncover opportunities to further reduce infection-related complications.
RESUMO
OBJECTIVE: To determine the impact of industry payments to authors of opinion articles on the Urolift and Rezum devices. We also examined the extent to which authors omitted acknowledgements of financial conflicts-of-interest. METHODS: We searched Google Scholar for all articles that cite either of the respective pivotal trials for these devices. 2 blinded urologists coded the articles as favorable or neutral. A separate blinded researcher recorded industry payments from the manufacturers using the Open Payments Program database. RESULTS: We identified 29 articles written by 27 unique authors from an initial screening list of 235 articles. Of these articles, 15 (52%) were coded as positive and 14 (48%) were coded as neutral. 20 (74%) authors have accepted payments from the manufacturer of the device. Since 2014, these authors have collectively received $270,000 from NeoTract and $314,000 from Boston Scientific. Of the 20 authors with payments, 9 (45%) received more than $10,000 from either manufacturer. Of authors with payments, 65% (13/20) contributed to only positive articles. Authors who received payments had more than 4 times the number of article contributions than did authors without payments (42 vs 10). Authors of at least one favorable article were more likely to have received payments from the device manufacturers than authors of neutral articles (P = .014, Chi-squared test). Most (80%, 16/20) authors with payments did not report a relevant conflict-of-interest within any of their articles. CONCLUSION: These data suggest a relationship between payments from a manufacturer and positive published position on that company's device. There may be a critical lack of published editorial pieces by authors without financial conflicts of interest.
Assuntos
Conflito de Interesses/economia , Equipamentos e Provisões/economia , Setor de Assistência à Saúde , Editoração , Revelação , Declarações Financeiras/estatística & dados numéricos , Setor de Assistência à Saúde/economia , Setor de Assistência à Saúde/ética , Humanos , Sintomas do Trato Urinário Inferior/terapia , Má Conduta Profissional , Editoração/economia , Editoração/ética , Estados Unidos , Urologistas/economia , Urologistas/éticaRESUMO
Introduction: Percutaneous nephrolithotomy (PCNL) is the gold standard treatment for patients with a large stone burden. There are a variety of methods to teach this important endourologic procedure, including simulation. We evaluated three different PCNL simulation platforms for potential use in teaching and assessing percutaneous renal access skills. Materials and Methods: Urology residents, fellows, and faculty were recruited to participate in this study, which included completing standardized tasks on three PCNL simulation platforms: a virtual reality (VR) simulator (PercMentor, 3D Systems™), a porcine tissue simulator (Cook™ Medical), and a new 3D immersive VR simulator-Marion K181 (Marion Surgical™). Participants were asked to complete a standardized task-gaining prone percutaneous renal access using a fluoroscopic-guided technique. Participants were asked to rate the simulators, and performance data were recorded for analysis. Results: A total of 18 participants with varying levels of PCNL experience completed the study. The Marion K181 had higher ratings by participants in all domains (realism, tactile feedback, instrument movement, renal anatomy, fidelity of simulation, utility as teaching tool) compared with the PercMentor (p < 0.05) but did not differ in any domain when compared with the porcine PCNL model. Participants felt that the Marion K181 was comparable with the porcine PCNL model as a teaching tool, but had the advantage of not requiring radiation exposure. Fluoroscopy time was the variable that most consistently correlated with participant PCNL experience and level of training, across all three PCNL simulation platforms. Conclusions: There are a variety of PCNL simulation platforms available for teaching percutaneous renal access skills. Based on our initial comparative study, there is validity evidence to support the use of the novel Marion K181 PCNL simulator as a training tool rather than higher fidelity models requiring real radiation exposure. However, evidence is yet lacking for its use as an assessment tool.
Assuntos
Nefrolitotomia Percutânea , Treinamento por Simulação , Realidade Virtual , Animais , Competência Clínica , Simulação por Computador , Humanos , SuínosRESUMO
OBJECTIVE: To determine how effective routine postoperative blood work is in identifying complications after percutaneous nephrolithotomy (PCNL), the gold standard treatment for large volume stone disease. Although major complication rates are low, hemorrhagic and sepsis-related complications are serious and can occur. Routine post-PCNL complete blood count is routinely performed by most endourologists but may be a low-value practice. METHODS: A retrospective review was performed of all PCNL procedures at our center over a 3-year period. Patient demographic, stone characteristics and postoperative data were collected and analyzed. RESULTS: Three hundred and eighty-five patients (196 female and 189 males) underwent PCNL for the treatment of urolithiasis. Mean age was 55.8 years and mean length of stay in hospital was 1.74 days. Most patients (82.9%) had neither ureteric stent nor percutaneous tube prior to PCNL. Postoperatively, 4 patients (1.0%) required a blood transfusion and 14 patients (3.6%) developed urosepsis. Patients who required either a transfusion or developed urosepsis demonstrated abnormal vital signs (tachycardia, hypotension, or fever) postoperatively. Sixteen patients (4.2%) had normal vital signs but had an extended hospital stay only to monitor abnormal blood work results. None these patients required a transfusion nor developed urosepsis but had a length of stay that was a mean of 1.5 days longer patients with normal postoperative vital signs and blood work. CONCLUSION: Abnormal vital signs alone identified all patients that required transfusion or treatment for urosepsis after PCNL. Routine complete blood count testing postoperatively may not improve detection of infectious or bleeding complications and may prolong hospital admission unnecessarily.
Assuntos
Testes Hematológicos , Cálculos Renais , Nefrolitotomia Percutânea , Complicações Pós-Operatórias , Hemorragia Pós-Operatória , Sepse , Transfusão de Sangue/estatística & dados numéricos , Canadá/epidemiologia , Feminino , Testes Hematológicos/métodos , Testes Hematológicos/estatística & dados numéricos , Humanos , Cálculos Renais/epidemiologia , Cálculos Renais/patologia , Cálculos Renais/cirurgia , Tempo de Internação/estatística & dados numéricos , Cuidados de Baixo Valor , Masculino , Uso Excessivo dos Serviços de Saúde/prevenção & controle , Pessoa de Meia-Idade , Nefrolitotomia Percutânea/efeitos adversos , Nefrolitotomia Percutânea/métodos , Nefrolitotomia Percutânea/estatística & dados numéricos , Avaliação de Resultados em Cuidados de Saúde , Complicações Pós-Operatórias/sangue , Complicações Pós-Operatórias/diagnóstico , Hemorragia Pós-Operatória/sangue , Hemorragia Pós-Operatória/etiologia , Hemorragia Pós-Operatória/terapia , Padrões de Prática Médica/normas , Padrões de Prática Médica/tendências , Estudos Retrospectivos , Sepse/sangue , Sepse/etiologia , Sepse/terapia , Índice de Gravidade de DoençaRESUMO
For over 35 years shock wave lithotripsy has proven to be an effective, safe and truly minimally invasive option for the treatment of nephrolithiasis. Various technical factors as well as patient selection can impact the success of the procedure. We used published work focusing on outcomes of shock wave lithotripsy, risk of complications, and strategies for improving stone fragmentation to create this review. Multiple patient and technical factors have been found to impact success of treatment. Skin to stone distance, stone density and composition, size and location of the stone within the urinary system all influence stone free rates. A slower rate with a gradual increasing voltage, precise targeting, proper coupling will improve stone fragmentation and decrease risk of complications. The selection of appropriate patients through a shared decision making process and attention to the technical factors that improve stone free rates is key to providing an effective treatment and patient satisfaction.
RESUMO
INTRODUCTION: Muscle-invasive bladder cancer (MIBC) is associated with high recurrence and mortality rates. The role of radiotherapy as an adjunct to radical cystectomy is not well-defined. We sought to evaluate the efficacy and safety of radiotherapy preoperatively or postoperatively for patients with MIBC receiving cystectomy compared to cystectomy alone. The primary outcome was overall survival. The secondary outcome was adverse effects. METHODS: MEDLINE, EMBASE, and CENTRAL were searched on August 30, 2016 for randomized controlled trials (RCTs) of patients undergoing cystectomy for bladder cancer. A control group receiving cystectomy alone and an intervention group with radiotherapy and cystectomy were required. The Jadad score was used to assess for bias. Fifteen studies representing 10 RCTs met eligibility criteria. RESULTS: A total of 996 patients were randomized in seven trials included in a meta-analysis of neoadjuvant radiotherapy. Insufficient data were available to complete a pooled analysis for adjuvant radiotherapy. There was a non-statistically significant improvement in overall survival for patients who received neo-adjuvant radiotherapy and cystectomy. At three years and five years, the odds ratios were 1.23 (95% confidence interval [CI] 0.72-2.09) and 1.26 (95% CI 0.76-2.09), respectively, in favour of neoadjuvant radiotherapy. Subgroup analyses including higher doses of radiotherapy showed greater effect on survival. CONCLUSIONS: These data suggest that radiotherapy prior to cystectomy may improve overall survival. This review was limited by old studies, heterogeneous patient populations, and radiotherapy treatment techniques that may not meet current standards. There is a need for current RCTs to further evaluate this effect.
RESUMO
INTRODUCTION: The role of ureteric stenting in renal transplant has been well-demonstrated. The goal of this survey was to determine the utilization of ureteric stents by Canadian transplant surgeons, and how the ureteroneocystotomy and followup is performed. METHODS: An online survey was sent to the 40 surgeon members of the Canadian Society of Transplantation. The primary outcome was the rate of ureteric stent use at the time of renal transplantation. The secondary outcomes were the ureteric stent dwell time, use and type of prophylactic antibiotics, and the use of routine post-transplant ultrasonography. RESULTS: All respondents (25) used ureteric stent routinely and 92% remove the stent between four and six weeks postoperatively. Prophylactic antibiotics were used 64% of the time for ureteric stent removal. The majority of surgeons do not routinely perform a post-stent removal ultrasound. Fifty-six percent of respondents perform a refluxing anastomosis. CONCLUSIONS: Ureteric stents are routinely used in renal transplant in Canada. Areas for improvement and topics of debate identified from this survey are the need for peri-stent removal antibiotics, the role of post-stent removal ultrasound, the duration of stent dwell time, and the need for a non-refluxing ureteroneocystotomy.
RESUMO
PURPOSE OF REVIEW: We set out to review the current published experience with robotic autotransplantation. Although the experience to date is limited, this surgery appears to be safe and technically feasible. We also examined the use of the robotic surgical platform for the management of post-transplant uretero-vesical anastomotic strictures. RECENT FINDINGS: To date, only four reported cases of robotic autotransplantation have been described with two being performed completely intra-corporeally. An intra-corporeal approach is feasible for benign conditions, while malignant masses should be inspected and dissected extra-corporeally. Ureteric strictures after renal transplantation are common. To date, the experience with robotic surgical management is limited but has also been shown to be safe and feasible. While robotic autotransplantation is still in its infancy, it is feasible and appears to be safe. Renal allograft function and surgical outcomes are favorable and provide patients the option to have a historically more morbid surgery performed with a minimally invasive approach.
Assuntos
Transplante de Rim/efeitos adversos , Transplante de Rim/métodos , Procedimentos Cirúrgicos Robóticos , Doenças Ureterais/cirurgia , Neoplasias Urológicas/cirurgia , Anastomose Cirúrgica/efeitos adversos , Constrição Patológica , Humanos , Rim/cirurgia , Recidiva , Transplante Autólogo , Ureter/patologia , Ureter/cirurgia , Bexiga Urinária/cirurgiaRESUMO
Keratinizing desquamative squamous metaplasia (KDSM) in the renal pelvis is a rare condition with unclear malignant potential. Recent reports suggest it is likely benign and favor endoscopic treatment approaches. Medical record review was completed on two cases at our center to obtain history, physical examination, radiographic findings, and management. A literature review was completed to identify all published cases of KDSM. Both patients at our center suffered recurrent urolithiasis, hypothesized to be secondary to KDSM. Both were managed with a percutaneous approach to ensure complete stone and KDSM plaque removal. Our cases highlight that percutaneous surgery is an excellent management option for stone and KDSM eradication from the collecting system. This approach also allows adequate oncologic surveillance of the underlying urothelium.
Assuntos
Pelve Renal , Nefrolitíase , Urotélio , Biópsia/métodos , Feminino , Humanos , Queratinas/metabolismo , Pelve Renal/diagnóstico por imagem , Pelve Renal/patologia , Litotripsia/métodos , Masculino , Metaplasia , Pessoa de Meia-Idade , Nefrolitíase/complicações , Nefrolitíase/diagnóstico , Nefrolitíase/fisiopatologia , Nefrolitíase/cirurgia , Recidiva , Tomografia Computadorizada por Raios X/métodos , Resultado do Tratamento , Urotélio/diagnóstico por imagem , Urotélio/metabolismo , Urotélio/patologiaRESUMO
CONTEXT: Hyperglycemia is common in deceased donors, and provokes numerous adverse events in hepatocytic mitochondria. OBJECTIVE: To determine whether hyperglycemia in deceased donors is associated with graft dysfunction after orthotopic liver transplant. METHODS: Charts on 572 liver transplants performed at the Cleveland Clinic between January 2005 and October 2010 were reviewed. The primary measure was time-weighted averages of donors' glucose measurements. Liver graft dysfunction was defined as (1) primary nonfunction as indicated by death or retransplant or (2) liver graft dysfunction as indicated by an aspartate amino transferase level greater than 2000 U/L or prothrombin time greater than 16 seconds during the first postoperative week. The relationship of interest was estimated by using a multivariable logistic regression. RESULTS: The incidence of graft dysfunction was 25%. No significant relationship was found between the range of donor glucose measurements and liver graft dysfunction after donor characteristics were adjusted for (P= .14, Wald test, adjusted odds ratio [95% CI] for liver graft dysfunction corresponding to a relative doubling in time-weighted average for donor glucose of 1.43 [0.89-2.30]). The results thus do not suggest that strict glucose control in donors is likely to improve graft quality.
Assuntos
Hiperglicemia/complicações , Hepatopatias/etiologia , Transplante de Fígado , Doadores de Tecidos , Feminino , Rejeição de Enxerto , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de RiscoRESUMO
Obesity is among the great health problems facing Americans today. More than 32% of the US population is considered obese on the basis of a body mass index (BMI) exceeding 30 kg/m(2) . Obesity increases the risk for numerous perioperative complications, but how obesity affects the outcome of liver transplantation remains unclear. We compared graft/patient survival after orthotopic liver transplantation performed at the Cleveland Clinic between April 2005 and June 2011 in 2 groups: obese patients with a BMI ≥ 38 kg/m(2) and lean patients with a BMI between 20 and 26 kg/m(2) . We included 47 obese patients and 183 lean patients, whose demographics and baseline characteristics were well balanced after weighting with the inverse propensity score. After we controlled for observed confounding, no significant differences were observed in graft/patient survival between obese and lean patients (P = 0.30). The estimated hazard ratio for obese patients to experience graft failure or death was 1.19 [95% confidence interval (CI) = 0.85-1.67]. There were 134 patients who had follow-up for more than 3 years, and they included 27 obese patients and 107 lean patients. Within this subset, the odds of having metabolic syndrome were significantly greater for obese patients (46%) versus lean patients (21%; odds ratio = 4.76, 99.5% CI = 1.66-13.7, P < 0.001). However, no significant association between obesity and any other long-term adverse outcomes was found. In conclusion, this study shows that transplant outcomes were comparable for lean and obese recipients. We thus recommend that even morbid obesity per se should not exclude patients from consideration for transplantation.
Assuntos
Sobrevivência de Enxerto , Falência Hepática/complicações , Falência Hepática/terapia , Obesidade/complicações , Idoso , Índice de Massa Corporal , Feminino , Humanos , Unidades de Terapia Intensiva , Falência Hepática/mortalidade , Transplante de Fígado , Masculino , Pessoa de Meia-Idade , Razão de Chances , Complicações Pós-Operatórias/mortalidade , Modelos de Riscos Proporcionais , Estudos Retrospectivos , Risco , Resultado do TratamentoRESUMO
BACKGROUND: Anemia has been associated with increased postoperative morbidity and mortality. We used the American College of Surgeons National Surgical Quality Improvement Program database to retrospectively assess the relationship between preoperative anemia and 30-day postoperative mortality and morbidity in noncardiac surgical patients, careful to distinguish confounding variables from mediator variables. METHODS: Each patient with preoperative anemia was matched to one without anemia using propensity matching on potentially confounding baseline variables. Logistic regression was used to evaluate the relationship between preoperative anemia and 30-day postoperative mortality and morbidity. The primary hypothesis was evaluated after adjusting for covariables showing residual imbalance after matching. RESULTS: Within the database, 574,860 of 971,455 surgical cases met our inclusion criteria, and among those 145,218 (25.3%) were anemic at baseline. The unadjusted odds ratio (95% confidence interval) for 30-day mortality comparing anemic patients with nonanemic patients was 4.69 (4.01-5.49). Among the propensity-matched group of 238,596 patients, the total effect (i.e., not adjusting for mediator variables) of preoperative anemia was estimated as an odds ratio of 1.59 (1.42-1.78). After adjusting for suspected mediator variables, preoperative anemia was only weakly associated with an odds ratio of 1.24 (1.10-1.40) for 30-day mortality. CONCLUSION: Preoperative anemia appears to be associated with baseline diseases that markedly increase mortality. Anemia per se is a rather weak independent predictor of postoperative mortality. Our analysis also illustrates how analyzing large variable-rich registries challenges investigators to discriminate between confounding variables and mediator variables, i.e., factors that might be considered as "causal pathways" for the effect of the exposure or intervention on outcome.
Assuntos
Anemia/mortalidade , Complicações Pós-Operatórias/mortalidade , Cuidados Pré-Operatórios/mortalidade , Adulto , Idoso , Anemia/diagnóstico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Morbidade , Complicações Pós-Operatórias/diagnóstico , Cuidados Pré-Operatórios/tendências , Estudos Prospectivos , Estudos Retrospectivos , Fatores de TempoRESUMO
PURPOSE: To provide outcomes data to intensivists and surgeons for counseling patients and family members when considering a surgical intervention in a moribund patient. MATERIALS AND METHODS: Retrospective analysis of prospectively collected data from the American College of Surgeons National Surgical Quality Improvement Program database in moribund patients undergoing general surgical procedures. RESULTS: Out of 633,262 patients available in the national registry, 2063 (0.3%) were of moribund status. Post-operative mortality was 52.8% for moribund patients. Those who died had higher rates of compromised respiratory, renal and cognitive dysfunction, were older, less independent prior to surgery and had generally longer surgeries. 83% of patients experienced a major complication including mortality and 17 % of patients experienced minor complications. CONCLUSION: The moribund patient is not as grave as once thought and surgery on these patients may not be futile given the 47% survival rate at 30 days. Postoperative complication rates are high. The data presented provide a meaningful tool for the clinicians in counseling patients and families on the expectations when considering a surgical intervention for moribund patients.
Assuntos
Aconselhamento , Estado Terminal , Avaliação de Resultados em Cuidados de Saúde , Procedimentos Cirúrgicos Operatórios , Idoso , Distribuição de Qui-Quadrado , Feminino , Mortalidade Hospitalar , Humanos , Incidência , Masculino , Complicações Pós-Operatórias/mortalidade , Melhoria de Qualidade , Sistema de Registros , Estudos Retrospectivos , Fatores de Risco , Estatísticas não Paramétricas , Procedimentos Cirúrgicos Operatórios/mortalidade , Taxa de SobrevidaRESUMO
OBJECTIVE: Between 2002 and 2008, over 100 patients with glottic carcinoma have undergone transoral laser microsurgical (TLM) resection at the QEII Health Sciences Centre in Halifax, Nova Scotia. The objective of this study was to assess the oncologic outcomes for all cases staged as T2 in this cohort. METHODS: A prospective database was developed to monitor outcomes. All 36 cases of primary T2 glottic carcinoma were selected from the database for analysis. Kaplan-Meier survival analyses evaluated the following end points at 36 months: overall survival, disease-specific survival, and local control and disease-free survival with one procedure. RESULTS: The Kaplan-Meier estimates of 36-month outcomes were 89% (SE 6.0%) overall survival and disease-specific survival, 81% (SE 7.1%) local control with one procedure, and 70% (SE 8.0%) disease-free survival with one procedure. CONCLUSIONS: The observed 36-month outcomes support the use of TLM as the primary treatment modality for T2 glottic cancers.
Assuntos
Neoplasias Laríngeas/patologia , Laringectomia/métodos , Terapia a Laser/métodos , Microcirurgia/métodos , Cirurgia Endoscópica por Orifício Natural/métodos , Recidiva Local de Neoplasia/epidemiologia , Estadiamento de Neoplasias , Idoso , Idoso de 80 Anos ou mais , Feminino , Glote , Humanos , Incidência , Neoplasias Laríngeas/cirurgia , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/patologia , Nova Escócia/epidemiologia , Estudos Prospectivos , Taxa de Sobrevida/tendências , Resultado do TratamentoRESUMO
BACKGROUND: Serum gentamicin concentrations (GSCs) are frequently obtained before and after gentamicin administration to newborns with, or at high risk for, sepsis. OBJECTIVE: To determine whether performing a peak GSC assay when the trough GSC is within the guidelines for care would add clinically relevant information for health care workers. METHODS: A retrospective review of the IWK Health Centre (Halifax, Nova Scotia) laboratory database for peak and trough GSC for infants <28 days after birth was performed. RESULTS: Of 5253 paired samples of trough and peak GSCs, 3001 (57%) had trough GSCs ≤2 µg/mL. Of these, only nine (0.3%) had a peak GSC >10 µg/mL. CONCLUSIONS: Performing a peak GSC measurement does not provide further clinically important data and increases patient morbidity and hospital costs.
HISTORIQUE: On vérifie souvent les concentrations de gentamicine sérique avant et après l'administration de gentamicine aux nouveau-nés présentant une septicémie ou qui y sont très vulnérables. OBJECTIF: Déterminer si l'obtention de la valeur de pointe de la concentration de gentamicine sérique (CGS) lorsque la valeur seuil respecte les lignes directrices de soins ajoute de l'information pertinente sur le plan clinique pour les travailleurs de la santé. MÉTHODOLOGIE: Analyse rétrospective de la base de données du laboratoire de l'IWK Health Centre à l'égard des valeurs de pointe et des valeurs seuils du CGS obtenues chez des bébés de moins de 28 jours de vie. RÉSULTATS: Des 5 253 échantillons appariés, 3 001 (57 %) avaient une valeur seuil de la CGS égale ou inférieure à 2 µg/mL. De ce nombre, seulement neuf (0,3 %) avaient une valeur de pointe de la CGS supérieure à 10 µg/mL. CONCLUSIONS: L'obtention de la valeur de pointe de la CGS ne fournit pas de nouvelles données importantes sur le plan clinique, sans compter qu'elle accroît la morbidité des patients et les coûts pour l'hôpital.
RESUMO
BACKGROUND: Damage to the central nervous system by Multiple Sclerosis (MS) leads to multiple symptoms, including weakness, ambulatory dysfunction, visual disturbances and fatigue. Heat can exacerbate the symptoms of MS whereas cooling can provide symptomatic relief. Since the head and neck areas are particularly sensitive to cold and cooling interventions, we investigated the effects of cooling the head and neck for 60 minutes on the symptoms of MS. METHODS: We used a double blinded, placebo controlled, cross-over study design to evaluate the effects of head and neck cooling on six heat-sensitive, stable, ambulatory females with MS (Extended Disability Status Scale 2.5-6.5). To isolate the effects of perceived versus physiological cooling, a sham cooling condition was incorporated, where subjects perceived the sensation of being cooled without any actual physiological cooling. Participants visited the clinic three times for 60 minutes of true, sham, or no cooling using a custom head and neck cooling hood, followed by evaluation of ambulation, visual acuity, and muscle strength. Rectal and skin temperature, heart rate, and thermal sensation were measured throughout cooling and testing. RESULTS: Both the true and sham cooling elicited significant sensations of thermal cooling, but only the true cooling condition decreased core temperature by 0.37 °C (36.97 ± 0.21 to 36.60 ± 0.23 °C). True cooling improved performance in the six minute walk test and the timed up-and-go test but not visual acuity or hand grip strength. CONCLUSIONS: Head and neck cooling may be an effective tool in increasing ambulatory capacity in individuals with MS and heat sensitivity.
Assuntos
Crioterapia/métodos , Cabeça/fisiologia , Temperatura Alta/efeitos adversos , Esclerose Múltipla/complicações , Parestesia/etiologia , Parestesia/terapia , Adulto , Análise de Variância , Temperatura Corporal/fisiologia , Avaliação da Deficiência , Método Duplo-Cego , Feminino , Humanos , Pessoa de Meia-Idade , Fatores de Tempo , CaminhadaRESUMO
Impaired manual functioning often occurs when the hands are exposed to cold temperatures, but the underlying mechanism is not clearly understood. Tactile feedback is thought to provide important information during object manipulations in order to scale and regulate grip forces; however, topical anaesthetic-induced tactile sensation impairments may not realistically simulate the systemic neuromuscular impairment of the whole hand that could occur during cold temperature exposure. In two experiments, we studied the impact of (1) local hand cooling [thermoneutral finger skin temperature, cold (<8 degrees C)] and (2) core body temperature (thermoneutral core body temperature, pre-heated by 0.5 degrees C, pre-cooled by 0.5 degrees C) with cold hands on manual dexterity and the ability to control and co-ordinate grip forces during a cyclical load-lifting task. In Experiment 1 (n = 10), hand cooling significantly decreased Purdue Pegboard performance (P = 0.002), while increasing grip force by approximately 5 N during the cyclical load-lifting task compared to thermoneutral (P = 0.037). The temporal co-ordination of grip and load forces was unaffected by hand cooling. In Experiment 2 (n = 11), pegboard performance was impaired following hand cooling (P < 0.001), and to a greater extent when the body was pre-cooled (p < 0.001). However, neither grip force (P = 0.99) nor the temporal co-ordination of grasping and lifting forces (P = 0.85) were affected by core body temperature. These data support the existence of a robust centrally controlled feedforward system able to anticipate the dynamics of manual manipulations and accordingly regulate the temporal co-ordination of fingertip forces during object manipulation. This centrally controlled mechanism appears to differ from the mechanisms governing other aspects of manual dexterity.
Assuntos
Temperatura Corporal/fisiologia , Força da Mão/fisiologia , Temperatura Cutânea/fisiologia , Suporte de Carga/fisiologia , Adolescente , Adulto , Temperatura Baixa , Feminino , Humanos , Masculino , Contração Muscular/fisiologia , Músculo Esquelético/fisiologia , Análise e Desempenho de Tarefas , Tato/fisiologiaRESUMO
Cold-induced vasodilatation (CIVD) is proposed to be a protective response to preserve tissue integrity in the extremities during cold exposure, but little research exists on either the trainability or the spatial pattern of CIVD response in the foot. We investigated the thermal response across the foot with repeated cold exposure. Ten healthy subjects immersed their left foot to the ankle in 8 degrees C water for 30 min 5 days/week for 3 weeks. Skin temperature was recorded on the medial side of the nail bed of the 5 toes and the dorsum of the foot. The presence of CIVD, defined as an increase of 1 degrees C at any time during cooling, was rare with our protocol. While a CIVD response was observed at least once in 8 of the 10 subjects, only 122 instances of CIVD were observed out of a total of 900 possible observations (10 subjects x 6 sites x 15 trials). Furthermore, thermal habituation was not evident, with toe temperatures at the end of each immersion (8-11 degrees C) remaining near water temperature throughout the 15 sessions. Even within the two subjects exhibiting the most incidence of CIVD, high variability existed in the occurrence, magnitude, and/or onset times. Synchronicity was often observed where more than one toe exhibited CIVD, though the magnitude varied greatly (range 1-9 degrees C). We conclude that, under realistic conditions of whole-foot immersion in cold water, CIVD is not a common or trainable response.